Protocol Ledger

NCT07019675 · Phase II · RECRUITING

A Study of SKB518 in Patients With Lung Cancer

Interventional Phase II clinical trial protocol NCT07019675 sponsored by Sichuan Kelun-Biotech Biopharmaceutical Co in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-08-29 Enrollment: 192 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07019675
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)192 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07019675
Protocol FieldVerified Registry Value
NCT IdentifierNCT07019675
Consolidated Lead SponsorSichuan Kelun-Biotech Biopharmaceutical Co
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment192 participants (ESTIMATED)
Registered Start Date2025-08-29
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI